1. Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data 
Dr Anna Maria van Eijk, MD, Jenny Hill, MSc, Victor A Alegana, BSc, Viola Kirui, BSc, Peter W Gething, PhD, Prof Feiko O ter Kuile, MD, Prof Robert W Snow, FMedSci 
The Lancet Infectious Diseases 
Volume 11, Issue 3, Pages (March 2011)
DOI: /S (10)
Copyright © 2011 Elsevier Ltd Terms and Conditions

2. Figure 1
Malaria risk (A), IPTp policy adoption (B), ITN coverage in women aged 15–49 years (C), IPTp coverage of at least one dose of sulfadoxine–pyrimethamine from any source (D), and ANC coverage (E) in countries in sub-Saharan Africa
Ethiopia and Burundi have no IPTp policy (D), but data were collected for sulfadoxine–pyrimethamine use in pregnant women in the last-available survey; Mauritania, Congo, and the Central African Republic had no IPTp policy at the time of the survey; Chad and Guinea adopted IPTp <1 year before the survey. ADMIN1=first-level administrative unit. IPTp=intermittent preventive treatment in pregnancy. ITN=insecticide-treated net. ANC=antenatal clinic.
The Lancet Infectious Diseases  , DOI: ( /S (10) )
Copyright © 2011 Elsevier Ltd Terms and Conditions

3. Figure 2
Flow diagram for calculation of number of pregnancies protected against malaria by ITNs or IPTp in sub-Saharan Africa for a hypothetical pregnant population in 2007
IPTp=intermittent preventive treatment in pregnancy. ITN= insecticide-treated net. ANC=antenatal clinic. PfPR2–10=predicted annual mean prevalence of Plasmodium falciparum in children aged 2–10 years. ADMIN1=first-level administrative unit.
The Lancet Infectious Diseases  , DOI: ( /S (10) )
Copyright © 2011 Elsevier Ltd Terms and Conditions

4. Figure 3
Coverage of SP intermittent preventive treatment (A) and estimated number of pregnant women who received at least two doses of SP, one from an ANC, projected for 2007 (B)
SP=sulfadoxine–pyrimethamine. ANC=antenatal clinic. DR Congo=Democratic Republic of the Congo. *Nigeria: 6 150 000 pregnancies per year.
The Lancet Infectious Diseases  , DOI: ( /S (10) )
Copyright © 2011 Elsevier Ltd Terms and Conditions